This topic contains a solution. Click here to go to the answer

Author Question: If 1 = 4.0 V, 2 = 12.0 V, R1 = 4 , R2 = 12 , C = 3 F, Q = 18 C, and I = 2.5 A, what is the ... (Read 21 times)

Mr3Hunna

  • Hero Member
  • *****
  • Posts: 536

If 1 = 4.0 V, 2 = 12.0 V, R1 = 4 , R2 = 12 , C = 3 F, Q = 18 C, and I = 2.5 A, what is the potential difference Va  Vb?
 
   


   
  a.
  30 V
   
  b.
  30 V
   
  c.
  5.0 V
   
  d.
  5.0 V
   
  e.
  1.0 V

Question 2

If R = 3.0 k, C = 6.0 nF, 1 = 10.0 V, Q = 18 nC, 2 = 6.0 V, and I = 5.0 mA, what is the potential difference Vb  Va?
 
   


   
  a.
  13 V
   
  b.
  +28 V
   
  c.
  +13 V
   
  d.
  28 V
   
  e.
  +2.0 V



Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

iman

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

a

Answer to Question 2

d




iman

  • Sr. Member
  • ****
  • Posts: 334

 

Did you know?

Only one in 10 cancer deaths is caused by the primary tumor. The vast majority of cancer mortality is caused by cells breaking away from the main tumor and metastasizing to other parts of the body, such as the brain, bones, or liver.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library